当前位置: X-MOL 学术Clin. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Adverse reactions in a large cohort of patients with inborn errors of immunity receiving intravenous immunoglobulin
Clinical Immunology ( IF 4.5 ) Pub Date : 2021-08-19 , DOI: 10.1016/j.clim.2021.108826
Hossein Esmaeilzadeh 1 , Aida Askarisarvestani 2 , Nazanin Hosseini 3 , Sahar Samimi 4 , Alireza Shafiei 5 , Seyed Alireza Mahdaviani 6 , Narges Eslami 7 , Zahra Chavoshzadeh 7 , Mazdak Fallahi 7 , Nasrin Khakbazanfard 7 , Mahnaz Sadeghi Shabestari 8 , Soheila Aleyasin 1 , Seyed Hesamedin Nabavizadeh 1 , Taher Cheraghi 9 , Arash Kalantari 10 , Akefeh Ahmadiafshar 11 , Mojgan Safari 12 , Mohammad Hossein Eslamian 12 , Rasol Molatefi 13 , Afshin Shirkani 14 , Marzieh Heidarzadeh Arani 15 , Marzieh Tavakol 16 , Mohammad Hassan Bemanian 17 , Saba Arshi 17 , Mohammad Nabavi 17 , Sima Shokri 17 , Babak Shahhosseini 2 , Negar Mortazavi 18 , Pooria Nakhaei 3 , Farzad Nazari 4 , Morteza Fallahpour 17 , Hamid Ahanchian 19 , Nasrin Moazzen 19 , Maryam Khoshkhui 19 , Ahmad Vosughi Motlagh 20 , Asghar Aghamohammadi 4 , Hassan Abolhassani 21 , Reza Yazdani 4 , Nima Rezaei 4
Affiliation  

Background

Intravenous immunoglobulins (IVIg) are the major treatment in inborn errors of immunity (IEI) disorders; However, IVIg infusions show some adverse effects. We aimed to assess the adverse reactions of IVIg infusions.

Methods

Data of IVIg infusions in IEI patients were collected from 2011 to 2021. Totally, 363 IEI patients received IVIg regularly in Iran entered the study. The adverse reactions are classified regarding their severity and chronicity.

Results

22,667 IVIg infusions were performed in the study. 157 patients (43.2%) and 1349 (5.9%) infusions were associated with at least one type of adverse reaction. The highest rates of adverse reactions were seen in severe combined immunodeficiency. Myalgia, chills, headache, fever, and hypotension were the most frequent adverse effects of IVIg.

Conclusion

The reactions affect almost half of the patients mainly in the first infusions which necessitate the close observation of IEI patients receiving IVIg.



中文翻译:

大量先天免疫缺陷患者接受静脉注射免疫球蛋白的不良反应

背景

静脉注射免疫球蛋白 (IVIg) 是先天性免疫缺陷 (IEI) 疾病的主要治疗方法;然而,IVIg 输注显示出一些不利影响。我们旨在评估 IVIg 输注的不良反应。

方法

收集了 2011 年至 2021 年 IEI 患者 IVIg 输注的数据。总共有 363 名伊朗 IEI 患者定期接受 IVIg 进入研究。不良反应根据其严重程度和长期性进行分类。

结果

研究中进行了 22,667 次 IVIg 输注。157 名患者 (43.2%) 和 1349 名 (5.9%) 输注与至少一种类型的不良反应相关。严重联合免疫缺陷的不良反应发生率最高。肌痛、寒战、头痛、发烧和低血压是 IVIg 最常见的不良反应。

结论

反应影响几乎一半的患者,主要是在第一次输注时,这需要密切观察接受 IVIg 的 IEI 患者。

更新日期:2021-08-21
down
wechat
bug